BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30783757)

  • 21. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
    Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
    Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer's disease?
    Aalinkeel R; Kutscher HL; Singh A; Cwiklinski K; Khechen N; Schwartz SA; Prasad PN; Mahajan SD
    J Drug Target; 2018 Feb; 26(2):182-193. PubMed ID: 28697660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer.
    Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinspired ginsenoside Rg3 PLGA nanoparticles coated with tumor-derived microvesicles to improve chemotherapy efficacy and alleviate toxicity.
    Zhang S; Zheng B; Wei Y; Liu Y; Yang L; Qiu Y; Su J; Qiu M
    Biomater Sci; 2024 May; 12(10):2672-2688. PubMed ID: 38596867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo.
    Yang LQ; Wang B; Gan H; Fu ST; Zhu XX; Wu ZN; Zhan DW; Gu RL; Dou GF; Meng ZY
    Biopharm Drug Dispos; 2012 Nov; 33(8):425-36. PubMed ID: 22898996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness.
    Wang J; Tian L; Khan MN; Zhang L; Chen Q; Zhao Y; Yan Q; Fu L; Liu J
    Cancer Lett; 2018 Feb; 415():73-85. PubMed ID: 29199005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted delivery of platinum-taxane combination therapy in ovarian cancer.
    Desale SS; Soni KS; Romanova S; Cohen SM; Bronich TK
    J Control Release; 2015 Dec; 220(Pt B):651-9. PubMed ID: 26381902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
    Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
    Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity.
    Junmin S; Hongxiang L; Zhen L; Chao Y; Chaojie W
    J Tradit Chin Med; 2015 Aug; 35(4):440-4. PubMed ID: 26427115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
    Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
    Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
    Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
    Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
    Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
    Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(L-Glutamic Acid)-Drug Conjugates for Chemo- and Photodynamic Combination Therapy.
    Yu H; Bao Y; Xu C; Chen L; Tang Z
    Macromol Biosci; 2021 Jan; 21(1):e2000192. PubMed ID: 33043592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly(ethylene glycol)‑poly(ε‑caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid.
    Kuo YC; Chang YH; Rajesh R
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():114-128. PubMed ID: 30606517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.